Abstract: The present invention relates to an electrolyte additive including a compound represented by Chemical Formula 1, an electrolyte including the electrolyte additive, and a secondary battery including the electrolyte. Chemical Formula 1: R1 and R2 are each independently an alkylene group having 1-5 carbon atoms; E1 is a bond, an alkylene group having 1-3 carbon atoms, or a cyclic carbonyl group, ether group, or ester group having 2-5 carbon atoms; R3 is a substituted or unsubstituted linear or cyclic carbonate group, carbonyl group, ether group, phosphate group, sulfonate group, or sulfate group having 2-5 carbon atoms; the substitution refers to substitution with one or more selected from F, Cl, Br, and I or an alkenyl group having 1-3 carbon atoms; E2 is a bond or a saturated or unsaturated alkylene group or ether group having 1-3 carbon atoms; and n is 0 or 1.

Abstract: The present invention relates to an electrolyte additive including a compound containing a substituent represented by Chemical Formula 1, an electrolyte including the electrolyte additive, and a secondary battery including the electrolyte. Chemical Formula 1: In Chemical Formula 1, P and O are phosphorus and oxygen, respectively; A is a bond or oxygen; Q is oxygen or an unshared electron pair; R1, R2, R3, and R4 are each independently hydrogen, a linear or branched alkyl group having 1 to 10 carbon atoms, an alkenyl group, an alkynyl group, an alkoxy group, an alkoxycarbonyl group, an alkoxyalkyl group, a fluoroalkyl, or a cyclic sulfate; optionally, R1 or R2 is connected to R3 or R4 to form a double bond or a ring; n is an integer from 0 to 3; and * is a binding position.

Abstract: The present invention relates to an electrolyte additive, a battery electrolyte including the electrolyte additive, and a secondary battery, and more particularly, to an electrolyte additive including a compound represented by Chemical Formula 1, an electrolyte including the electrolyte additive, and a secondary battery including the electrolyte. According to the present invention, due to low charging resistance, charging efficiency and output may be improved. In addition, the present invention has an effect of providing a secondary battery having a long lifespan and excellent capacity retention at high temperature.

Abstract: A probiotic for inhibiting and preventing the progression of a renal disease and a composition containing the same are disclosed. The probiotic contains a novel Lactobacillus acidophilus BP105 strain, a novel Lactobacillus salivarius BP121 strain. The novel probiotics, the Lactobacillus acidophilus BP105 strain and the Lactobacillus salivarius BP121 strain exhibit excellent indoxyl sulfate removal ability, p-cresol removal ability, and phosphorus absorption ability.

Abstract: The present invention pertains to a Lonicera Japonica flower water extract composition for preventing or treating Helicobacter pylori infection, the composition containing secoxyloganin as an active ingredient. The extract contains a specific amount of secoxyloganin, and thus exhibited excellent antibacterial effects when used on Helicobacter pylori bacteria, and exhibited excellent effects in terms of reducing Helicobacter pylori IgG antibody expression in the blood, alleviating histopathological lesions, and reducing cytokine expression when used on Helicobacter pylori-infected mice. Thus, the Lonicera Japonica flower water extract of the present invention can be usefully used as a composition for preventing or treating Helicobacter pylori infection.

Abstract: The present invention relates to a composition for promoting myogenesis, containing, as an active ingredient, a processed ginseng extract in which a trace amount of a ginsenoside ingredient is increased. It has been ascertained that the processed ginseng extract promotes the differentiation of myoblasts into muscle and inhibits muscle atrophy caused by myostatin, which is a myogenesis inhibitory factor, and thus it is expected that a composition for preventing or treating muscle disorder-related diseases, having excellent effects, can be developed.

Abstract: A probiotic for inhibiting and preventing the progression of a renal disease and a composition containing the same are disclosed. The probiotic contains a novel Lactobacillus acidophilus BP105 strain, a novel Lactobacillus salivarius BP121 strain. The novel probiotics, the Lactobacillus acidophilus BP105 strain and the Lactobacillus salivarius BP121 strain exhibit excellent indoxyl sulfate removal ability, p-cresol removal ability, and phosphorus absorption ability.

Abstract: The present invention provides a cosmetic composition and a pharmaceutical composition comprising secretions of natural killer cells, which are excellent in increasing various factors related to improvement of atopic dermatitis, hair loss, wounds or skin wrinkles, and in enhancing an expression level, and thereby having excellent alleviation effects on the symptoms.

Abstract: The present invention relates to a leveling agent and electroplating composition comprising the same. When features are plated using the electroplating composition of the present invention, excellently leveled plated surfaces with minimized defects may be obtained.

Abstract: The present invention relates to a composition for cobalt plating and a method for forming metal wiring using the same, and more particularly, a composition for cobalt plating comprising a cobalt salt; a chloride or a hydrochloric acid; boric acid; a carbonaceous material; and other additives, and a method for forming a metal wiring using the same, in which the composition for cobalt plating is plated onto a substrate to suppress the thermal expansion of the metal caused by high-temperature processes to achieve excellent high-temperature stability, thereby resulting in prevention of deformation of a substrate even in the absence of any structural modification of the substrate or additional processing.

Abstract: The present invention relates to a leveling agent and electroplating composition comprising the same. When features are plated using the electroplating composition of the present invention, excellently leveled plated surfaces with minimized defects may be obtained.

Abstract: Disclosed is a composition for treating or preventing gastroesophageal reflux disease, which includes an organic solvent extract of Lonicerae Flos Thunberg. A fraction of the disclosed extract can be very effectively used for treating, preventing, or improving gastroesophageal reflux disease without side effects.